Bank of Montreal’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bank of Montreal’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,243	Closed	-$54.9K	–	4452
2022 Q4	$54.9K	Sell	33,243 -1,570	-5%	-$2.08K	﹤0.01%	3520
2022 Q3	$73	Sell	34,813 -200,794	-85%	-$455K	﹤0.01%	3544
2022 Q2	$492	Buy	235,607 +178,716	+314%	+$309K	﹤0.01%	2706
2022 Q1	$144K	Buy	56,891 +45,045	+380%	+$140K	﹤0.01%	3567
2021 Q4	$57K	Sell	11,846 -1,578	-12%	-$9.8K	﹤0.01%	3220
2021 Q3	$105K	Buy	13,424 +3,252	+32%	+$27.6K	﹤0.01%	3441
2021 Q2	$101K	Sell	10,172 -62,959	-86%	-$501K	﹤0.01%	3326
2021 Q1	$566K	Sell	73,131 -80,821	-52%	-$853K	﹤0.01%	2564
2020 Q4	$1.11M	Buy	153,952 +128,294	+500%	+$1.03M	﹤0.01%	2177
2020 Q3	$272K	Sell	25,658 -4,646	-15%	-$42.5K	﹤0.01%	2595
2020 Q2	$235K	Buy	30,304 +28,734	+1,830%	+$110K	﹤0.01%	2648
2020 Q1	$3K	Sell	1,570 -15,802	-91%	-$45.5K	﹤0.01%	3816
2019 Q4	$58K	Sell	17,372 -158,613	-90%	-$378K	﹤0.01%	3779
2019 Q3	$376K	Sell	175,985 -124,556	-41%	-$290K	﹤0.01%	2575
2019 Q2	$802K	Buy	300,541 +9,780	+3%	+$35.2K	﹤0.01%	2188
2019 Q1	$1.38M	Buy	290,761 +281,884	+3,175%	+$740K	﹤0.01%	1880
2018 Q4	$21K	Sell	8,877 -147,909	-94%	-$483K	﹤0.01%	3633
2018 Q3	$690K	Buy	156,786 +47,916	+44%	+$266K	﹤0.01%	2173
2018 Q2	$784K	Buy	+108,870	New	+$741K	﹤0.01%	2126
2017 Q2	–	Sell	-488	Closed	-$2K	–	4337
2017 Q1	$2K	Hold	488	–	–	﹤0.01%	3846
2016 Q4	$3K	Hold	488	–	–	﹤0.01%	3847
2016 Q3	$4K	Hold	488	–	–	﹤0.01%	3767
2016 Q2	$3K	Buy	+488	New	+$3.12K	﹤0.01%	3853

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Bank of Montreal's SRNE Position: Q1 2023 in Review

Bank of Montreal sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 33,243 shares — an estimated $54.9K sold.

Bank of Montreal first reported a position in SRNE in Q2 2016 and held it in 23 quarters. The position peaked at $1.38M in Q1 2019. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Bank of Montreal reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 33,243 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $54.9K.
Bank of Montreal first reported a position in Sorrento Therapeutics, Inc. in Q2 2016 and held it in 23 quarters.
Bank of Montreal's Sorrento Therapeutics, Inc. position peaked at $1.38M in Q1 2019.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.